• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病的骨骼肌病理学。

Skeletal muscle pathology in Huntington's disease.

机构信息

Department of Social Medicine, Poznan University of Medical Sciences Poznan, Poland.

MRC National Institute for Medical Research London, UK.

出版信息

Front Physiol. 2014 Oct 6;5:380. doi: 10.3389/fphys.2014.00380. eCollection 2014.

DOI:10.3389/fphys.2014.00380
PMID:25339908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4186279/
Abstract

Huntington's disease (HD) is a hereditary neurodegenerative disorder caused by the expansion of a polyglutamine stretch within the huntingtin protein (HTT). The neurological symptoms, that involve motor, cognitive and psychiatric disturbances, are caused by neurodegeneration that is particularly widespread in the basal ganglia and cereberal cortex. HTT is ubiquitously expressed and in recent years it has become apparent that HD patients experience a wide array of peripheral organ dysfunction including severe metabolic phenotype, weight loss, HD-related cardiomyopathy and skeletal muscle wasting. Although skeletal muscles pathology became a hallmark of HD, the mechanisms underlying muscular atrophy in this disorder are unknown. Skeletal muscles account for approximately 40% of body mass and are highly adaptive to physiological and pathological conditions that may result in muscle hypertrophy (due to increased mechanical load) or atrophy (inactivity, chronic disease states). The atrophy is caused by degeneration of myofibers and their replacement by fibrotic tissue is the major pathological feature in many genetic muscle disorders. Under normal physiological conditions the muscle function is orchestrated by a network of intrinsic hypertrophic and atrophic signals linked to the functional properties of the motor units that are likely to be imbalanced in HD. In this article, we highlight the emerging field of research with particular focus on the recent studies of the skeletal muscle pathology and the identification of new disease-modifying treatments.

摘要

亨廷顿病(HD)是一种遗传性神经退行性疾病,由亨廷顿蛋白(HTT)内的多聚谷氨酰胺延伸引起。涉及运动、认知和精神障碍的神经症状是由神经退行性变引起的,这种退行性变在基底神经节和大脑皮层中特别广泛。HTT 广泛表达,近年来,人们已经清楚地认识到 HD 患者会出现多种外周器官功能障碍,包括严重的代谢表型、体重减轻、与 HD 相关的心肌病和骨骼肌消耗。尽管骨骼肌病理学已成为 HD 的标志,但该疾病中肌肉萎缩的机制尚不清楚。骨骼肌约占体重的 40%,对生理和病理条件具有高度适应性,这些条件可能导致肌肉肥大(由于机械负荷增加)或萎缩(不活动、慢性疾病状态)。萎缩是由肌纤维变性和纤维组织取代引起的,这是许多遗传性肌肉疾病的主要病理特征。在正常生理条件下,肌肉功能由内在肥大和萎缩信号网络协调,这些信号与运动单位的功能特性相关,而在 HD 中这些信号可能会失衡。本文强调了新兴的研究领域,特别是最近对骨骼肌病理学和新的疾病修饰治疗的研究。

相似文献

1
Skeletal muscle pathology in Huntington's disease.亨廷顿病的骨骼肌病理学。
Front Physiol. 2014 Oct 6;5:380. doi: 10.3389/fphys.2014.00380. eCollection 2014.
2
Transcriptional Signature of an Altered Purine Metabolism in the Skeletal Muscle of a Huntington's Disease Mouse Model.亨廷顿舞蹈病小鼠模型骨骼肌中嘌呤代谢改变的转录特征
Front Physiol. 2017 Mar 2;8:127. doi: 10.3389/fphys.2017.00127. eCollection 2017.
3
Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.正常化糖皮质激素水平可减轻亨廷顿病 R6/2 小鼠模型的代谢和神经病理学症状。
Neurobiol Dis. 2019 Jan;121:214-229. doi: 10.1016/j.nbd.2018.09.025. Epub 2018 Oct 5.
4
Beyond the brain: widespread pathology in Huntington's disease.超越大脑:亨廷顿舞蹈症的广泛病变
Lancet Neurol. 2009 Aug;8(8):765-74. doi: 10.1016/S1474-4422(09)70178-4.
5
A shared mechanism of muscle wasting in cancer and Huntington's disease.癌症和亨廷顿舞蹈症中肌肉萎缩的共同机制。
Clin Transl Med. 2015 Dec;4(1):34. doi: 10.1186/s40169-015-0076-z. Epub 2015 Dec 14.
6
Molecular Mechanisms Underlying Muscle Wasting in Huntington's Disease.亨廷顿病中肌肉减少的分子机制。
Int J Mol Sci. 2020 Nov 5;21(21):8314. doi: 10.3390/ijms21218314.
7
Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.亨廷顿病相关行为、细胞和病理特征的促进:亨廷顿病基因缺失在神经节内侧和外侧谱系中差异破坏区域中间神经元和投射神经元亚型。
J Neurosci. 2019 Mar 6;39(10):1892-1909. doi: 10.1523/JNEUROSCI.2443-18.2018. Epub 2019 Jan 9.
8
The Expanding Clinical Universe of Polyglutamine Disease.聚谷氨酰胺疾病的临床领域不断扩大。
Neuroscientist. 2019 Oct;25(5):512-520. doi: 10.1177/1073858418822993. Epub 2019 Jan 7.
9
Deterioration of neuroregenerative plasticity in association with testicular atrophy and dysregulation of the hypothalamic-pituitary-gonadal (HPG) axis in Huntington's disease: A putative role of the huntingtin gene in steroidogenesis.与亨廷顿病的睾丸萎缩和下丘脑-垂体-性腺 (HPG) 轴失调相关的神经再生可塑性恶化:亨廷顿基因在类固醇生成中的潜在作用。
J Steroid Biochem Mol Biol. 2020 Mar;197:105526. doi: 10.1016/j.jsbmb.2019.105526. Epub 2019 Nov 9.
10
Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.亨廷顿病 HdhQ150 敲入小鼠模型中非 CNS 组织中聚谷氨酰胺包涵体的形成。
PLoS One. 2009 Nov 30;4(11):e8025. doi: 10.1371/journal.pone.0008025.

引用本文的文献

1
Silent destruction: hidden muscle wasting and body decline in early Huntington's disease.无声的破坏:早期亨廷顿舞蹈症中隐匿的肌肉萎缩和身体衰退
J Neural Transm (Vienna). 2025 Jul 28. doi: 10.1007/s00702-025-02991-3.
2
The role of the gut microbiota in neurodegenerative diseases targeting metabolism.肠道微生物群在以代谢为靶点的神经退行性疾病中的作用。
Front Neurosci. 2024 Sep 26;18:1432659. doi: 10.3389/fnins.2024.1432659. eCollection 2024.
3
Brain-Periphery Interactions in Huntington's Disease: Mediators and Lifestyle Interventions.

本文引用的文献

1
Dysfunction of the CNS-heart axis in mouse models of Huntington's disease.亨廷顿舞蹈症小鼠模型中中枢神经系统-心脏轴的功能障碍
PLoS Genet. 2014 Aug 7;10(8):e1004550. doi: 10.1371/journal.pgen.1004550. eCollection 2014 Aug.
2
Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission.亨廷顿舞蹈病中线粒体裂变增加与神经元功能障碍:对过度线粒体裂变分子抑制剂的启示
Drug Discov Today. 2014 Jul;19(7):951-5. doi: 10.1016/j.drudis.2014.03.020. Epub 2014 Mar 28.
3
HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration.
亨廷顿病的脑-外周相互作用:介导因素和生活方式干预。
Int J Mol Sci. 2024 Apr 25;25(9):4696. doi: 10.3390/ijms25094696.
4
Transmission-selective muscle pathology induced by the active propagation of mutant huntingtin across the human neuromuscular synapse.突变型亨廷顿蛋白在人类神经肌肉突触间的主动传播所引发的传导选择性肌肉病变。
Front Mol Neurosci. 2024 Jan 3;16:1287510. doi: 10.3389/fnmol.2023.1287510. eCollection 2023.
5
An exploratory metabolomic comparison of participants with fast or absent functional progression from 2CARE, a randomized, double-blind clinical trial in Huntington's disease.对 2CARE 中功能快速或无进展的参与者进行探索性代谢组学比较,2CARE 是一项针对亨廷顿病的随机、双盲临床试验。
Sci Rep. 2024 Jan 11;14(1):1101. doi: 10.1038/s41598-023-50553-y.
6
Huntington's Disease Drug Development: A Phase 3 Pipeline Analysis.亨廷顿舞蹈症药物研发:一项3期管线分析
Pharmaceuticals (Basel). 2023 Oct 24;16(11):1513. doi: 10.3390/ph16111513.
7
Rapamycin reduces neuronal mutant huntingtin aggregation and ameliorates locomotor performance in .雷帕霉素可减少神经元中突变型亨廷顿蛋白的聚集,并改善其运动能力。
Front Aging Neurosci. 2023 Sep 26;15:1223911. doi: 10.3389/fnagi.2023.1223911. eCollection 2023.
8
Extremely elevated creatine kinase associated with rhabdomyolysis-induced acute kidney injury in a patient with Huntington's disease: a case report.亨廷顿病患者横纹肌溶解症致急性肾损伤患者肌酸激酶极度升高:病例报告。
J Med Case Rep. 2023 Jul 10;17(1):287. doi: 10.1186/s13256-023-04018-5.
9
A minimal region of the HSP90AB1 promoter is suitable for ubiquitous expression in different somatic tissues with applicability for gene therapy.HSP90AB1启动子的一个最小区域适用于在不同体细胞组织中进行普遍表达,可用于基因治疗。
Front Mol Biosci. 2023 Apr 17;10:1175407. doi: 10.3389/fmolb.2023.1175407. eCollection 2023.
10
Home-Based Exercise to Improve Motor Functions, Cognitive Functions, and Quality of Life in People with Huntington's Disease: A Systematic Review and Meta-Analysis.基于家庭的运动对亨廷顿病患者运动功能、认知功能和生活质量的改善:系统评价和荟萃分析。
Int J Environ Res Public Health. 2022 Nov 12;19(22):14915. doi: 10.3390/ijerph192214915.
抑制组蛋白去乙酰化酶 4:一种针对细胞质亨廷顿蛋白的新型治疗策略,可改善神经退行性变。
PLoS Biol. 2013 Nov;11(11):e1001717. doi: 10.1371/journal.pbio.1001717. Epub 2013 Nov 26.
4
HDAC4 does not act as a protein deacetylase in the postnatal murine brain in vivo.组蛋白去乙酰化酶 4 在体内出生后小鼠脑中不作为一种蛋白去乙酰化酶发挥作用。
PLoS One. 2013 Nov 22;8(11):e80849. doi: 10.1371/journal.pone.0080849. eCollection 2013.
5
p53 increases caspase-6 expression and activation in muscle tissue expressing mutant huntingtin.p53 增加了表达突变 huntingtin 的肌肉组织中 caspase-6 的表达和激活。
Hum Mol Genet. 2014 Feb 1;23(3):717-29. doi: 10.1093/hmg/ddt458. Epub 2013 Sep 18.
6
Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.在小鼠中对突变型亨廷顿蛋白的遗传操作:对亨廷顿病发病机制的新认识。
FEBS J. 2013 Sep;280(18):4382-94. doi: 10.1111/febs.12418. Epub 2013 Jul 31.
7
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.肌肉组蛋白去乙酰化酶 4 在肌萎缩侧索硬化症中的上调:在重新支配能力和疾病进展中的潜在作用。
Brain. 2013 Aug;136(Pt 8):2359-68. doi: 10.1093/brain/awt164. Epub 2013 Jul 3.
8
Huntington's disease: underlying molecular mechanisms and emerging concepts.亨廷顿病:潜在的分子机制和新出现的概念。
Trends Biochem Sci. 2013 Aug;38(8):378-85. doi: 10.1016/j.tibs.2013.05.003. Epub 2013 Jun 12.
9
Huntington disease skeletal muscle is hyperexcitable owing to chloride and potassium channel dysfunction.亨廷顿舞蹈病患者的骨骼肌由于氯离子和钾离子通道功能障碍而表现出过度兴奋。
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9160-5. doi: 10.1073/pnas.1220068110. Epub 2013 May 13.
10
Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/2 mouse model of HD.通过 R6/2 型亨廷顿病小鼠模型的纵向 MRI 和组织病理学评估,行为缺陷与脑病理学的相关性。
PLoS One. 2013 Apr 4;8(4):e60012. doi: 10.1371/journal.pone.0060012. Print 2013.